1. Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma
   Ioannis Koutsounas et al, 2015, Pancreas CrossRef
2. High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma
   Stamatios Theocharis et al, 2021, Diagnostics CrossRef
3. Inter‑component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma
   Andrzej Pyra et al, 2022, Oncology Letters CrossRef
4. Preoperative Diagnosis and Chemotherapy of Endometrial Stromal Sarcoma with Ultrasound Image Based on Nano Bubble
   Jingjing Bi et al, 2023, Journal of Biomedical Nanotechnology CrossRef
5. Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer
   Kari L. Ring et al, 2023, DiSaia and Creasman Clinical Gynecologic Oncology CrossRef
6. Hormone replacement therapy after treatment for a gynaecological malignancy
   Rachel Louise O’Donnell et al, 2016, Current Opinion in Obstetrics & Gynecology CrossRef
7. Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement
   A.K. Sinno et al, 2020, Gynecologic Oncology CrossRef
8. Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study ofTP53Gene Therapy
   Yu Xia et al, 2018, Human Gene Therapy CrossRef
9. Identification and characterization of a subpopulation of CD133+ cancer stem‐like cells derived from SK-UT-1 cells
   Jiuping Gao et al, 2021, Cancer Cell International CrossRef